|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 1.120 USD | -.--% |
|
-.--% | -22.76% |
| 13.07. | AB Science stellt drei klinische Studien zu Masitinib ein | MT |
| 10.07. | AB Science strafft sein Portfolio und konzentriert sich auf zwei Wirkstoffe |  |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.45% | +2.80% | +4.48% | +17.13% | +24.52% | +54.73% | +21.89% | +69.04% | +123.82% | 324 Mrd. | |
| -0.07% | +2.09% | -5.34% | +24.35% | +13.50% | +23.58% | -11.37% | -20.01% | +43.53% | 68.88 Mrd. | |
| +1.35% | +5.29% | +12.80% | +25.35% | +21.74% | +40.68% | +91.38% | +91.02% | +781.92% | 9.72 Mrd. | |
| +0.93% | -1.38% | +2.29% | +11.33% | +3.60% | +2.01% | -3.34% | -29.72% | +35.86% | 8.37 Mrd. | |
| +1.13% | +1.51% | -9.03% | -21.21% | -35.31% | -21.44% | -1.35% | -33.93% | - | 4.32 Mrd. | |
| +4.90% | +5.79% | +5.05% | -20.99% | -33.36% | -38.81% | +23.85% | +40.76% | +86.30% | 3.83 Mrd. | |
| -4.00% | +0.71% | -5.71% | +18.03% | +24.91% | -5.66% | +13.37% | -39.22% | - | 3.62 Mrd. | |
| -2.10% | -3.83% | +3.24% | -7.15% | -7.04% | +37.58% | +52.58% | +69.42% | +114.88% | 2.68 Mrd. | |
| -4.07% | -2.45% | -4.31% | -20.88% | -20.25% | -8.03% | -16.98% | +43.76% | - | 2.04 Mrd. | |
| -5.78% | +0.89% | +11.77% | -5.40% | -3.49% | -16.30% | +27.60% | -32.18% | - | 1.84 Mrd. | |
| -2.53% | -4.40% | +4.83% | -12.77% | -16.14% | -24.10% | -22.79% | -11.77% | -45.12% | 1.68 Mrd. | |
| -.--% | -.--% | - | - | - | - | - | - | - | 1.64 Mrd. | |
| -3.51% | +0.64% | +22.31% | +85.01% | +151.86% | +176.56% | +1’460.07% | +661.90% | - | 1.17 Mrd. | |
| +2.08% | +1.89% | -8.64% | -40.83% | -40.18% | +36.28% | +37.50% | +17.60% | +455.67% | 1.13 Mrd. | |
| -5.95% | -6.07% | -8.99% | -30.50% | -20.96% | -37.80% | -34.56% | - | - | 1.12 Mrd. | |
| -6.45% | -5.20% | -4.79% | +4.80% | +10.03% | +1.69% | +81.54% | +6.72% | - | 1.1 Mrd. | |
| +0.24% | +1.56% | +4.83% | -7.34% | -9.03% | -2.31% | +41.28% | +86.43% | +75.96% | 1.07 Mrd. | |
| -3.06% | -5.56% | -1.56% | -22.10% | -26.19% | -42.19% | -76.99% | -84.60% | - | 850 Mio. | |
| -2.89% | -0.84% | +0.86% | -16.07% | -15.47% | -43.91% | -13.92% | -50.11% | -66.38% | 840 Mio. | |
| Durchschnitt | -1.54% | -0.41% | +1.34% | -1.07% | +1.26% | +7.36% | +92.77% | +46.18% | +160.64% | 23.14 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.28% | +2.06% | +2.79% | +16.78% | +20.32% | +44.83% | +20.96% | +51.38% | +123.44% |
- Börse
- Aktien
- A1CXBG Aktie
- A1CXBG Aktie
- Sektor AB Science
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
